Joyce A. Korvick

3.0k total citations · 1 hit paper
35 papers, 2.2k citations indexed

About

Joyce A. Korvick is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Joyce A. Korvick has authored 35 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 14 papers in Infectious Diseases and 6 papers in Molecular Medicine. Recurrent topics in Joyce A. Korvick's work include Antibiotic Resistance in Bacteria (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Mycobacterium research and diagnosis (6 papers). Joyce A. Korvick is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Mycobacterium research and diagnosis (6 papers). Joyce A. Korvick collaborates with scholars based in United States and Thailand. Joyce A. Korvick's co-authors include Victor L. Yu, Robert R. Muder, Sten H. Vermund, Jeffrey J. Zuravleff, Maury E. Mulligan, Carol A. Kauffman, Bruce S. Ribner, Harold C. Standiford, Joseph F. John and Victor L. Yu and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Joyce A. Korvick

35 papers receiving 2.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management

1993 542 citations Maury E. Mulligan, Bruce S. Ribner et al. The American Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joyce A. Korvick United States	21	901	727	385	324	324	35	2.2k
Francisc Schlaeffer Israel	24	429 0.5×	735 1.0×	233 0.6×	163 0.5×	527 1.6×	80	2.0k
Angelo Pan Italy	24	1.1k 1.2×	550 0.8×	287 0.7×	243 0.8×	527 1.6×	69	2.2k
Klaris Riesenberg Israel	26	535 0.6×	878 1.2×	504 1.3×	192 0.6×	897 2.8×	89	2.6k
P. Chavanet France	35	1.7k 1.9×	1.6k 2.1×	168 0.4×	373 1.2×	335 1.0×	186	3.5k
Young Goo Song South Korea	31	921 1.0×	1.3k 1.8×	324 0.8×	91 0.3×	416 1.3×	220	3.3k
Yu‐Chung Chuang Taiwan	27	909 1.0×	1.0k 1.4×	373 1.0×	119 0.4×	613 1.9×	122	2.3k
Alessandra Oliva Italy	30	1.0k 1.1×	918 1.3×	149 0.4×	415 1.3×	694 2.1×	178	3.6k
Gary J. Noel United States	32	1.2k 1.3×	1.1k 1.5×	384 1.0×	93 0.3×	473 1.5×	88	3.2k
Nam Su Ku South Korea	26	837 0.9×	859 1.2×	140 0.4×	173 0.5×	252 0.8×	168	2.5k
Stan Deresinski United States	30	1.9k 2.1×	1.3k 1.7×	556 1.4×	105 0.3×	214 0.7×	106	3.4k

Countries citing papers authored by Joyce A. Korvick

Since Specialization

Citations

This map shows the geographic impact of Joyce A. Korvick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce A. Korvick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce A. Korvick more than expected).

Fields of papers citing papers by Joyce A. Korvick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce A. Korvick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce A. Korvick. The network helps show where Joyce A. Korvick may publish in the future.

Co-authorship network of co-authors of Joyce A. Korvick

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce A. Korvick. A scholar is included among the top collaborators of Joyce A. Korvick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce A. Korvick. Joyce A. Korvick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Benson, Constance A., Paige L. Williams, David L. Cohn, et al.. (2000). Clarithromycin or Rifabutin Alone or in Combination for Primary Prophylaxis ofMycobacterium aviumComplex Disease in Patients with AIDS: A Randomized, Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases. 181(4). 1289–1297. 62 indexed citations

2.

Cohn, David L., Evelyn J. Fisher, James S. Hodges, et al.. (1999). A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients. 67. 1 indexed citations

3.

Cohn, David L., Evelyn J. Fisher, James S. Hodges, et al.. (1999). A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin. 67. 520–521. 1 indexed citations

4.

Cohn, David L., Evelyn J. Fisher, Grace Peng, et al.. (1999). Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin. Clinical Infectious Diseases. 29(1). 125–133. 43 indexed citations

5.

Korvick, Joyce A. & Constance A. Benson. (1996). Mycobacterium avium-complex infection: progress in research and treatment.. 34 indexed citations

6.

Valentine, Fred, Patrick Haslett, David Katzenstein, et al.. (1996). A Randomized, Placebo-Controlled Study of the Immunogenicity of Human Immunodeficiency Virus (HIV) rgp160 Vaccine in HIV-Infected Subjects with >=400/mm3 CD4 T Lymphocytes (AIDS Clinical Trials Group Protocol 137). The Journal of Infectious Diseases. 173(6). 1336–1346. 41 indexed citations

7.

Goldman, Anne I., Bradley P. Carlin, Lawrence R. Crane, et al.. (1996). Response of CD4 Lymphocytes and Clinical Consequences of Treatment Using ddI or ddC In Patients with Advanced HIV Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(2). 161–169. 43 indexed citations

8.

Kessler, Harold A., S S Hurwitz, Charles Farthing, et al.. (1996). Pilot Study of Topical Trifluridine for the Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients with AIDS (ACTG 172). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(2). 147–152. 26 indexed citations

9.

Goldman, Anne I., et al.. (1995). Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS.. PubMed. 10 Suppl 2. S9–18. 7 indexed citations

10.

Gordin, Fred M., John P. Matts, Joyce A. Korvick, et al.. (1995). Two-Stage Tuberculin Skin Testing in Individuals with Human Immunodeficiency Virus Infection. American Journal of Respiratory and Critical Care Medicine. 151(3_Part_1). 805–808. 11 indexed citations

11.

Fleming, Thomas R., et al.. (1995). Insights from monitoring the CPCRA didanosine/zalcitabine trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 10. 11 indexed citations

12.

Dezube, Bruce J., Michael M. Lederman, B. A. Chapman, et al.. (1995). High-Dose Pentoxifylline in Patients with AIDS: Inhibition of Tumor Necrosis Factor Production. The Journal of Infectious Diseases. 171(6). 1628–1632. 37 indexed citations

13.

Abrams, Donald I., Anne I. Goldman, Cynthia A. Launer, et al.. (1994). A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 330(10). 657–662. 150 indexed citations

14.

Mulligan, Maury E., Bruce S. Ribner, Harold C. Standiford, et al.. (1993). Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. The American Journal of Medicine. 94(3). 313–328. 542 indexed citations breakdown →

15.

Abrams, Donald I., et al.. (1992). Organization, goals, and logistical challenges of the community programs for clinical research on aids. Controlled Clinical Trials. 13(5). 408–409. 1 indexed citations

16.

Kessler, Harold A., Constance A. Benson, John C. Pottage, et al.. (1992). Actg 172 treatment of acyclovir resistant acv r mucocutaneous herpes simplex virus hsv infection in patients with aids open label pilot study of topical trifluridine tft. 55. 2 indexed citations

17.

Korvick, Joyce A., et al.. (1992). CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review. The Journal of Infectious Diseases. 165(2). 352–363. 236 indexed citations

18.

Yu, Victor L., et al.. (1989). Antibiotic therapy for pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients. The American Journal of Medicine. 87. 540–546. 36 indexed citations

19.

Korvick, Joyce A. & Victor L. Yu. (1988). Simultaneous Infection with <i>Cryptococcus neoformans</i> and <i>Legionella pneumophila</i>. Respiration. 53(2). 132–136. 5 indexed citations

20.

Korvick, Joyce A., et al.. (1987). Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: Old and new. Diagnostic Microbiology and Infectious Disease. 7(2). 107–111. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact